Abstract
A congealable disperse phase encapsulation method was used to prepare sustained-release ibuprofen-wax microspheres. Microspheres prepared with paraffin wax, such as ceresine and micro-crystalline waxes, using polyvinylpyrrolidone (PVP) as dispersant had a tendency to aggregate, but the addition of wax modifiers (stearyl alcohol and glyceryl monostearate) greatly reduced aggregation. Optimum modifier and dispersant concentrations were 20% (w/w) and 5% (w/v), respectively. The particle size distribution of the microspheres was log-normal. An increase in modifier, dispersant concentration, emulsification stirring speed, or temperature shifted the size distribution toward finer particles. Microcrystalline wax required a higher emulsification temperature and produced finer particles than ozokerite wax. The recovery of drug from the different microsphere formulations varied between 71 and 92%. Differential scanning calorimetry (DSC) of the single components and physical mixtures showed endothermic peaks at the respective melting-point ranges. The DSC of the ceresine and microcrystalline wax microspheres was similar to rescans of ternary mixtures of components of the microspheres with less prominent and lower melting temperatures than individual components or physical mixtures.
Similar content being viewed by others
REFERENCES
S. S. Adams and J. W. Buckler. Ibuprofen and flurbiprofen. E. D. Huskisson (ed.), In Anti-Rheumatic Drug, Praeger, Westport, Conn. 1983 p. 244.
S. S. Adams and J. W. Buckler, Ibid, p. 245.
J. A. Stead, M. Freeman, E. G. John, G. T. Ward, and B. Whiting. Ibuprofen tablets: Dissolution and bioavailability studies. Int. J. Pharm. 14:59–72 (1983).
A. Ali, S. Kasmi, T. Deutsch, and F. M. Plakogiannis. Medicament release from suppository bases. III. Ibuprofen-physicochemical characteristics and bioavailability in rabbits. Drug Dev. Ind. Pharm. 8(3):411–428 (1982).
A. Muktadir, A. Babar, A. J. Cutie, and F. M. Plakogiannis. Medicament release from ointment-bases. III. Ibuprofen: In vitro release and in vivo absorption in rabbits. Drug Dev. Ind. Pharm. 12(14):2521–2540 (1986).
S. L. Law and J. B. Kayes. Stability of suspensions in the presence of nonionic water soluble cellulose polymers. Drug Dev. Ind. Pharm. 10(7):1049–1069 (1984).
A. Fin, V. Zecchi, L. Rodriguez, and A. Tartarini. Solubility-dissolution relationship for ibuprofen, fenbufen and their sodium salts in acid medium. Pharm. Acta Helv. 59(4):106–108 (1984).
S. L. Law and J. B. Kayes. Adsorption of nonionic water soluble cellulose polymers at the solid-water interface and their effect on suspension stability. Int. J. Pharm. 15:251–260 (1983).
S. L. Law and J. B. Kayes. Stability of suspensions in the presence of nonionic water soluble cellulose polymers. Drug Dev. Ind. Pharm. 10(7).
Y. Kawashima. Development of agglomerated crystallization technique using new agglomeration phenomena of particles in liquid system and particle designs for pharmaceutical preparations. Yakugaku Zasshi 106(6):433–445 (1980).
C. A. Kagadis and N. H. Choulis. Ibuprofen microcapsules from stearic acid. Part 1: Effect of particle size. Pharmazie 40:807–808 (1985).
S. Benita, O. Zouiai, and J. P. Benoit. 5-Fluorouracil: Carnauba wax microspheres for chemoembolization: An in vitro evaluation. J. Pharm. Sci. 75(9):847–851 (1986).
A. G. Cusimano and C. H. Becker. Spray-congealed formulations of sulfaethylthiadiazole (SETD) and waxes for prolonged-release medication. Effect of wax. J. Pharm. Sci. 57(7):1104–1111 (1968).
P. M. John and C. H. Becker. Surfactants effects on spray-congealed formulations of sulfaethylthiadiazole-wax. J. Pharm. Sci. 57:584 (1968).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Adeyeye, C.M., Price, J.C. Development and Evaluation of Sustained-Release Ibuprofen-Wax Microspheres. I. Effect of Formulation Variables on Physical Characteristics. Pharm Res 8, 1377–1383 (1991). https://doi.org/10.1023/A:1015845022112
Issue Date:
DOI: https://doi.org/10.1023/A:1015845022112